QCLS
Q/C TECHNOLOGIES, INC.Company Information
- Company Name
- Q/C TECHNOLOGIES, INC.
- CIK
- CIK0001321834
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- QCLS: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2835
- SIC Description
- In Vitro & In Vivo Diagnostic Substances
- Ticker
- QCLS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-30
- Last sale
- —
- Shares purchased (TTM)
- 1,753
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 682,932
- Shares outstanding
- 8,235,978
- Ownership
- 8.29%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -38.06%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | 1 | 7 | 0 | 0 | 0 | 1 | 1 | 0 | 3 | 0 | ||||||
| Marketable Securities Current | 11 | 12 | 15 | 3 | 4 | 6 | 8 | 9 | 13 | 2 | 2 | 8 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 12 | 14 | 17 | 11 | 5 | 7 | 9 | 12 | 14 | 2 | 6 | 10 | ||||||
| Other Receivables Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Net | - | 14 | 14 | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 11 | 25 | 25 | 26 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | ||||||
| Operating Lease Right Of Use Asset | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Goodwill | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Other Assets | - | - | - | - | - | - | - | - | - | 2 | - | - | ||||||
| Investments | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | - | 2 | - | ||||||
| Long Term Investments | - | - | - | - | - | - | - | - | - | - | 2 | 2 | ||||||
| Other Assets Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 23 | 38 | 41 | 37 | 17 | 19 | 21 | 24 | 26 | 14 | 18 | 22 | ||||||
Liabilities | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 6 | 7 | 6 | 5 | 7 | 7 | 6 | 4 | 5 | 6 | ||||||
| Deferred Compensation Liability Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Dividends Payable Current | 0 | 1 | 0 | 0 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 2 | 2 | 2 | 3 | - | 0 | 1 | 1 | - | - | 0 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Deferred Compensation Liability Classified Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Liabilities Noncurrent | 0 | 11 | 11 | 9 | - | - | - | - | 20 | 0 | 0 | 0 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | 6 | 5 | 5 | 0 | 0 | 0 | 0 | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | 11 | 11 | 9 | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 4 | 15 | 16 | 16 | 6 | 5 | 7 | 7 | 26 | 4 | 5 | 6 | ||||||
Temporary Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 112 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 16 | 21 | 22 | 14 | 5 | 9 | 10 | 17 | 0 | 10 | 12 | 16 | ||||||
| Additional Paid In Capital | 168 | 166 | 166 | 152 | 139 | 140 | 139 | 143 | 123 | 123 | 114 | - | ||||||
| Retained Earnings Accumulated Deficit | -152 | -146 | -144 | -138 | -134 | -131 | -129 | -126 | -123 | -113 | -102 | -97 | ||||||
| Preferred Stock No Par Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities And Stockholders Equity | 23 | 38 | 41 | 37 | 17 | 19 | 21 | 24 | 26 | 14 | 18 | 22 | ||||||
| Temporary Stock Dividend Rate Percentage | - | 0 | 0 | - | - | 0 | 0 | - | - | 0 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Common Stock No Par Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 1,250 | 1,250 | 1,250 | 1,250 | 250 | 250 | 1,250 | 250 | 250 | 17 | 250 | 500 | ||||||
| Common Stock Shares Issued | 8 | 8 | 8 | 3 | 29 | 7 | 0 | 2 | 2 | 2 | 2 | 47 | ||||||
| Shares Outstanding | 8 | 8 | 8 | 3 | 29 | 7 | 0 | 2 | 2 | 2 | 2 | 47 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialQ/C TECHNOLOGIES, INC. (QCLS) — SEC Financial Statements & Analysis
Q/C TECHNOLOGIES, INC. (QCLS) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Q/C TECHNOLOGIES, INC. trades on Nasdaq as: QCLS. Q/C TECHNOLOGIES, INC. (QCLS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Q/C TECHNOLOGIES, INC. carries a market cap of $32.12M, a P/E ratio of -1.69x, a P/B ratio of 2.00x, a P/S ratio of -687.90x, an enterprise value of $31.81M, and an EV/EBITDA multiple of -2.25x. On profitability, it posts an operating margin of 30301.82%, a net margin of 40760.52%, a Return on Equity (ROE) of -178.14%, a Return on Assets (ROA) of -95.12%, and a Return on Invested Capital (ROIC) of -135.71%. Per share, it reports EPS of $-2.31, diluted EPS of $-2.31, free cash flow per share of $-1.17, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 84.28% year-over-year and EPS growth of -98.79% year-over-year. On the balance sheet, it maintains a current ratio of 3.29x, a quick ratio of 3.09x, working capital of $8.18M, a debt-to-equity ratio of 0.24x, a debt ratio of 0.17, free cash flow of $-9.61M (TTM), and net debt of $-307.61K. Figures sourced from SEC EDGAR.
- Market Cap
- $32.12M
- P/E TTM
- -1.69x
- EPS TTM
- $-2.31
- P/B TTM
- 2.00x
- ROE TTM
- -178.14%
- ROA TTM
- -95.12%
- Debt To Equity
- 0.24x
- Free Cash Flow TTM
- $-9.61M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Q/C TECHNOLOGIES, INC. in?
Q/C TECHNOLOGIES, INC. (QCLS) operates in the In Vitro & In Vivo Diagnostic Substances industry.
What exchange does QCLS trade on?
Q/C TECHNOLOGIES, INC. (QCLS) trades on the Nasdaq.
Where is Q/C TECHNOLOGIES, INC. incorporated?
Q/C TECHNOLOGIES, INC. is incorporated in DE.
When was Q/C TECHNOLOGIES, INC. (QCLS)'s most recent SEC filing?
Q/C TECHNOLOGIES, INC. (QCLS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is QCLS's market cap?
Q/C TECHNOLOGIES, INC. (QCLS) has a market capitalization of $32.12M as of 2026-06-30.
What is QCLS's EPS (earnings per share)?
Q/C TECHNOLOGIES, INC. (QCLS)'s trailing twelve month EPS is $-2.31 as of 2026-06-30.
What is QCLS's ROE (return on equity)?
Q/C TECHNOLOGIES, INC. (QCLS)'s trailing twelve month Return on Equity (ROE) is -178.14% as of 2026-06-30.
What is QCLS's ROA (return on assets)?
Q/C TECHNOLOGIES, INC. (QCLS)'s trailing twelve month Return on Assets (ROA) is -95.12% as of 2026-06-30.
What is QCLS's ROIC (return on invested capital)?
Q/C TECHNOLOGIES, INC. (QCLS)'s trailing twelve month Return on Invested Capital (ROIC) is -135.71% as of 2026-06-30.
What is QCLS's EV/EBITDA?
Q/C TECHNOLOGIES, INC. (QCLS)'s trailing twelve month EV/EBITDA is -2.25x as of 2026-06-30.